| Amy O'brien, MA SLP | |
|
150 Erie Ct, Amherst, OH 44001-1724 | |
| (440) 984-2416 | |
| (440) 984-2422 |
| Full Name | Amy O'brien |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 150 Erie Ct, Amherst, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285726752 | NPI | - | NPPES |
| 7255198 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP4916 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy O'brien, MA SLP 150 Erie Ct, Amherst, OH 44001-1724 Ph: (440) 984-2416 | Amy O'brien, MA SLP 150 Erie Ct, Amherst, OH 44001-1724 Ph: (440) 984-2416 |
News Archive
Schizophrenia and related psychotic disorders are a chronic and often disabling condition. Despite modern treatment techniques they still present an enormous burden to the patients and their relatives and take a serious toll in terms of human suffering and societal expenditure.
MedQuist Holdings Inc., formerly CBaySystems Holdings Limited, a leading provider of integrated clinical documentation solutions for the U.S. Healthcare system, today announced the pricing of its U.S. initial public offering of 4,500,000 shares of its common stock at a price to the public of $8.00 per share.
Anxiety is common in bipolar disorder patients experiencing an episode of acute mania and is associated with increased mood symptom severity, research shows.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.
BioTime, Inc. announced today that on August 1, 2010 the Company will be offering for sale 21 new stem cell products for research use only. These products will include the novel stem cell lines: E120 expressing the gene LGR5 useful in colon cancer drug discovery, EN16, T43, RAD20.5, RA-SKEL8, SM22, and Z1, full properties of which will be disclosed on product launch, along with differentiation kits and media for the culture of each line.
› Verified 6 days ago
Stacey L Whiteamire, M.A. CCC S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Erie Ct, Amherst, OH 44001 Phone: 440-984-2416 Fax: 440-984-2422 | |
Paige Gershman, M.A. S.L.P Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Erie Ct, Amherst, OH 44001 Phone: 440-984-2416 Fax: 440-984-2422 | |
Erin Gonzalez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1235 Meadowview Ln, Amherst, OH 44001 Phone: 440-308-5391 | |
Nancy E Anderson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Erie Ct, Amherst, OH 44001 Phone: 440-984-2416 Fax: 440-984-2422 | |
Ms. Maria Christine Gonzalez, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 197 N Leavitt Rd, Amherst, OH 44001 Phone: 315-481-7223 | |
Jennifer Alice Klemme, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Erie Ct, Amherst, OH 44001 Phone: 440-984-2416 | |
Lara Kovacs, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 633 Lincoln St, Amherst, OH 44001 Phone: 440-670-3136 |